TG Therapeutics Inc. (TGTX) Jumps 10.63% on January 14

Equities Staff |

TG Therapeutics Inc. (TGTX) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 10.63% to $9.37, representing a gain of $0.9 per share. Some 446,357 shares traded hands on 4,105 trades, compared with an average daily volume of 610,874 shares out of a total float of 52.52 million. The stock opened at $8.49 and traded with an intraday range of $9.37 to $8.37.

After today's gains, TG Therapeutics Inc. reached a market cap of $492.11 million. TG Therapeutics Inc. has had a trading range between $20.00 and $7.68 over the last year, and it had a 50-day SMA of $12.14 and a 200-day SMA of $14.26.

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of medically important pharmaceutical products for the treatment of cancer & other underserved therapeutic needs.

TG Therapeutics Inc. is based out of New York, NY and has some 30 employees. Its CEO is Michael S. Weiss.

For a complete fundamental analysis analysis of TG Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for TGTX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.